By the end of this topic, the student should be able to:
Health and social service professionals, such as dentists, physicians, pharmacists, nurses, and social workers, play a key role in providing client education.
Lucky7trader/iStock
Opioids are a group of medications that are very good at relieving pain.
Opioids work by blocking pain signals within the nervous system. Opioids can also help to reduce the stress and anxiety caused by pain.
Opioids are commonly known as “narcotics” or “opiates.” See the table below for some other common names.
Generic name | Trade name | Street names |
---|---|---|
buprenorphine | BuTrans | bupe, bute |
buprenorphine-naloxone | Suboxone | subby, bupe, sobos |
codeine | Tylenol 2, 3, 4 (codeine + acetaminophen) | cody, captain cody, T1, T2, T3, T4 |
fentanyl | Abstral, Duragesic, Onsolis | patch, sticky, sticker, nerps, beans |
hydrocodone | Tussionex, Vicoprofen | hydro, vike |
hydromorphone | Dilaudid | juice, dillies, dust |
meperidine | Demerol | demmies |
methadone | Methadose, Metadol | meth, drink, done |
morphine | Dorloral, Statex, M.O.S | M, morph, red rockets |
oxycodone | OxyNEO, Percocet, Oxycocet, Percodan | oxy, hillbilly heroin, percs |
pentazocine | Talwin | Ts |
tapentadol | Nucynta | unknown |
tramadol | Ultram, Tramacet, Tridural, Durela | chill pills, ultra |
Canadian Centre on Substance Use and Addiction. (2017). Canadian drug summary: Prescription opioids.
Take a moment to watch the following National Geographic video, explaining what happens in the brain when opioids are used.
Generally, opioids are prescribed after all other options are exhausted.
Opioids may be prescribed to:
NOTE: Not everyone experiencing these types of pain requires treatment with an opioid medication.
Opioids can help to improve a person’s ability to engage in activities that they were previously able to do before the pain.
There are significant risks to be aware of when using opioids. Be aware of the following side effects assicoated with opioid use:
Short-term side effects
NOTE: Short-term side effects can be mostly avoided by starting at a low dose and slowly (rather than quickly) increasing the dose.
Long-term side effects
Opioid use disorder is described in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
NOTE: In 2018, 1 in 10 Canadians reported misusing opioid medications in the previous year (Statistics Canada, 2018).
Tolerance results in a loss of the effect of a drug over time. This occurs when the body adapts to the continued presence of the drug.
Abrupt discontinuation of opioid medication after using it for a long time can cause a withdrawal reaction.
Signs of opioid overdose include
9-1-1 should be called immediately if a drug overdose is suspected. See Module 6 Topic D for more details.
If on hand, naloxone can be administered while waiting for emergency help to arrive.
Health and social service professionals should encourage opioid stewardship and work with various teams to provide well-rounded care.
Definition
In order to support safer use of opioids, be aware of the following facts and guidelines:
Did You Know?
Based on limited human data, the American Academy of Pediatrics has classified methadone as compatible with breastfeeding (American Academy of Pediatrics Committee on Drugs, 2001).
University of Waterloo (treatment regimen); formbyte/iStock (no alcohol); Vladislav Popov/iStock (no medication); no cannabis (Drypsiak/iStock); lukpedclub/iStock (no driving); Vladislav Popov/iStock (padlock icon); anttohoho/iStock (pharmacy building, no sharing); Nubenamo/iStock (not while pregnant);
As part of opioid stewardship, it is important to educate persons on the risks associated with short-term and long-term opioid use.
Definition
When the long-term risks outweigh the benefits or the client has minimal or no pain, it may be time to consider weaning off opioids.
NOTE: This plan should also be discussed with social supports and family members, if possible.
Rx files is a program that provides service to physicians throughout Saskatchewan. They have compiled a resource entitled Tapering Opoids. How to Explore and Pursue the Option for Patients Who Stand to Benefit (PDF). Use this resource as needed to learn more about opioid tapering.
When providing information to persons, families, support persons, communities, decision makers, Elders, other health and social service professionals, and the public regarding opioid use and opioid use disorder, community-specific harm reduction resources should be identified and contact information noted.
Health and social service providers should ensure they know the answers to the following questions:
In addition, health and social service providers should familiarize themselves with other services in the city or region, including what types of housing supports are available, the location and types of shelters, how to access emergency mental health or other supports, and any employment programming, as well as the types of withdrawal management and treatment services in the area.
For more information, visit the Canadian Centre on Substance Use and Addiction’s opioid resources page for a list of opioid harm reduction resources.
American Academy of Pediatrics Committee on Drugs. (2001). The transfer of drugs and other chemicals into human milk. Pediatrics, 108, 776–789.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).
Canadian Centre on Substance Abuse. (2017). Canadian drug summary: Prescription opioid, 2017. https://www.ccsa.ca/sites/default/files/2019-04/CCSA-Canadian-Drug-Summary-Prescription-Opioids-2017-en.pdf
Chang, F., Patel, T., Kluz, A., & Killeen, R. (2017). Module 2: Collaborative care: how and why. In Opioid Education Partnership. School of Pharmacy, University of Waterloo. Retrived from: https://opioidresource.ca/demo/m2-lesson.html
Costello, M. (2015). Prescription opioid analgesics: promoting patient safety with better patient education. American Journal of Nursing, 115(11), 50–56.
Hadi, I., da Silva, O., Natale, R., Boyd, D., & Morley-Forster, P. K. (2006). Opioids in the parturient with chronic nonmalignant pain: A retrospective review. Journal of Opioid Management, 2(1), 31–34.
Furlan, A. D., Sandoval, J. A., Mailis-Gagnon, A., & Tunks, E. (2006). Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects. CMAJ, 174(11), 1589–1594.
Institute for Safe Medication Practices Canada. (2017). Opioid pain medicines information for patients and families. https://www.ismp-canada.org/download/OpioidStewardship/opioid-handout-bw.pdf
Institute for Safe Medication Practices Canada (2021). Opioid Stewardship. https://www.ismp-canada.org/opioid_stewardship/
Lexi-Drugs Adult Patient Education. (2020). Morphine (systemic). Lexi-Comp. https://www.wolterskluwer.com/en/solutions/lexicomp
Lexi-Drugs monograph. (2020). Morphine (systemic). Lexi-Comp. https://www.wolterskluwer.com/en/solutions/lexicom
Madadi, P., Ross, C., Hayden, M., Carleton, B., Gaedigk, A., Leeder, J., & Koren, G. (2009). Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: A case–control study. Clinical Pharmacology & Therapeutics, 85(1), 31–35.
Michael G. DeGroote National Pain Centre. (2020). Canadian guidelines for safe and effective use of opioids for chronic non-cancer pain—Appendix B-4: Opioid information for patients. McMaster University. http://nationalpaincentre.mcmaster.ca/opioid/cgop_b_app_b04.html
Post, T. (Ed.). (2020). Patient education: Opioids for short-term treatment of pain (the basics). UpToDate.com. https://www.uptodate.com/contents/opioid-use-disorder-the-basics
Reisfield, G. M. (2010). Medical cannabis and chronic opioid therapy. Journal of Pain & Palliative Care Pharmacotherapy, 24(4), 356–361.
Statistics Canada. (2019). Canadian community health survey, 2018. https://www150.statcan.gc.ca/n1/daily-quotidien/190625/dq190625b-eng.htm